Allicin treatment (50 mg/kg) revealed to reduce TNF-α level and MPO activity, ameliorated infarct size, alleviated brain edema and improved the neurological score in the experimental MCAO ischemic stroke rat models (Zhang et al., 2015). This evidence concerns the gene MPO and ischemic stroke.